How much funding has AbCellera Biologics Inc. Common Shares raised?

AbCellera Biologics Inc. Common Shares has raised $115.8M in total funding, most recently a Series B round.

When was AbCellera Biologics Inc. Common Shares founded?

AbCellera Biologics Inc. Common Shares was founded in 2012.

Where is AbCellera Biologics Inc. Common Shares headquartered?

AbCellera Biologics Inc. Common Shares is headquartered in Vancouver, Canada.

What industry is AbCellera Biologics Inc. Common Shares in?

AbCellera Biologics Inc. Common Shares operates in Artificial Intelligence, Biotech, Healthcare.

How many employees does AbCellera Biologics Inc. Common Shares have?

AbCellera Biologics Inc. Common Shares has 201-500 employees.

AbCellera Biologics Inc. Common Shares

IPO

AbCellera

Public · Vancouver, Canada · Founded 2012 · $115.8M raised

Artificial Intelligence

Biotech

Healthcare

Headquarters: Vancouver
Employees: 201–500
Founded: 2012
Business Model: B2B
Website: abcellera.com

Total Funding: $115.8M
Last Round: $105.0M Series BMay 2020
Rounds: 3
Type: Public

About

AbCellera (Nasdaq: ABCL) is a Vancouver-based clinical-stage biotechnology company that uses AI-powered microfluidic technology and single-cell analysis to discover and develop antibody medicines. It has completed over 100 therapeutic discovery programs across diverse indications, and has pivoted from a partnership model to advancing its own pipeline in oncology, endocrinology, and immunology.

Summary

AbCellera Biologics Inc. Common Shares is an Artificial Intelligence company based in Vancouver, Canada, founded in 2012. It has raised $115.8M in total across 3 rounds, most recently a $105.0M Series B round in May 2020.

LinkedIn X (Twitter)